Supreme Court Asked To Weigh Hospira Drug-Shortage Suit
A woman who brought a class action targeting Hospira Inc. for ceasing production of an injectable form of vitamin A has asked the U.S. Supreme Court to review the Eleventh Circuit's...To view the full article, register now.
Already a subscriber? Click here to view full article